Destination therapy with a rotary blood pump and novel power delivery

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 2, 2010, Pages 350-356

  Westaby, Stephen ^a   Siegenthaler, Michael ^b   Beyersdorf, Friedhelm ^c   Massetti, Massimo ^d   Pepper, John ^e   Khayat, Andre ^d   Hetzer, Roland ^f   Frazier, Oscar Howard ^g  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UMPC Presbytarian ^*  (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

^d CAEN UNIVERSITY HOSPITAL   (France)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^f DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^g TEXAS HEART INSTITUTE   (United States)

Author keywords

Assist device; Heart failure; Jarvik; Long term

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PUMP; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; LONGEVITY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ASSISTED CIRCULATION; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; MINIATURIZATION; PROSTHESIS DESIGN; THORACOTOMY;

EID: 74149087253     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.03.071     Document Type: Article

References (24)

1. Redfield M.M. Heart failure-an epidemic of uncertain proportions. N Engl J Med 347 (2002) 1442-1444
2. Hoercher K.J., Nowicki E.R., Blackstore E.H., Singh G., Alster J.M., Gonzalez-Stawinski G.V., Starling R.C., Young J.B., and Smedira N.G. Prognosis of patients removed from a transplant waiting list for medical improvement: implications for organ allocation and transplantation for Status 2 patients. J Thorac Cardiovasc Surg 135 (2008) 1159-1166
3. Rose E.A., Gelijns A.C., Moskowitz A.J., Heitjan D.F., Stevenson L.W., Dembitsky W., Long J.W., Ascheim D.D., Tierney A.R., Levitan R.G., Watson J.T., Meier P., Ronan N.S., Shapiro P.A., Lazar R.M., Miller L.W., Gupta L., Frazier O.H., Desvigne-Nickens P., Ox M.C., Poirier V.L., and Randomised Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
4. Westaby S. Destination therapy. Time for real progress. Nat Clin Pract Cardiovasc Med 5 (2008) 477-483
5. Holman W.L., Park S.J., Long J.W., Weinberg A., Gupta L., Tierney A.R., Adamson R.M., Watson J.D., Raines E.P., Couper G.S., Pagani F.D., Burton N.A., Miller L.W., Naka Y., and REMATCH Investigators. Infection in permanent circulatory support experience from the REMATCH trial. J Heart Lung Transplant 23 (2004) 1359-1365
6. Haft J., Dyke D.B., Aaronson K.D., Koelling T.M., Farrar D.J., and Pagani F.D. Hemodynamic and exercise performance with pulsatile and continuous flow left ventricular assist devices. Circulation 116 Suppl. II (2007) I8-I15
7. Jarvik R., Westaby S., Katsumata T., Pigott D., and Evans R.D. LVAD power delivery: a percutaneous approach to avoid infection. Ann Thorac Surg 65 (1998) 470-473
8. Westaby S, Banning A, Neil D, Poole-Wilson P, Frazier OH. Optimism derived from 7.5 years continuous flow circulatory support. J Thorac Cardiovasc Surg, doi:10.1016/jtcvs.2008.05.072.
9. Siegenthaler M.P., Martin J., Gutwald R., Bahr R., Westaby S., Schmelzeisen R., and Beyersdorf F. Anterior approach to implant the Jarvik 2000 with retro-auricular power supply. Ann Thorac Surg 80 August (2) (2005) 745-747
10. Westaby S., Saito S., and Frazier O.H. Implant technique for the Jarvik 2000 heart. Ann Thorac Surg 123 (2002) 977-983
11. Grambsch P., and Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515-526
12. Parkin J.L. Percutaneous pedestal in cochlear implantation. Ann Otol Rhinol Largyngol 99 (1990) 798-800
13. Park S.J., Tector A., Piccioni W., Raines E., Gelijns A., Moskowitz A., Rose E., Holman W., Furukawa S., Frazier O.H., and Dembitsky W. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 129 (2005) 9-17
14. Leitz K., Long J.W., Kfoury A.G., Slaughter M.S., Silver M.A., Milano C.A., Rogers J.G., Naka Y., Mancini D., and Miller L.W. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116 (2007) 497-505
15. Miller L.W., Pagani F.D., Russell S.D., John R., Boyle A.J., Aaronson K.D., Conte J.V., Naka Y., Mancini D., Delgado R.M., MacGillivray T.E., Farrar D.J., Frazier O.H., and HeartMate II Clinical Investigators. Use of a continuous flow device in patients awaiting heart transplantation. N Eng J Med 357 (2007) 885-896
16. McAlister F.A., Ezekowitz J., Hooton N., Vandermeer B., Spooner C., Dryden D.M., Page R.L., Hlatky M.A., and Rowe B.H. Cardiac resynchronisation therapy for patients with left ventricular systolic dysfunction. A systematic review. JAMA 297 (2007) 2502-2514
17. Boyle A.J., Russell S.D., John R., Chen L., Aaronson K.D., Farrar D.J., and Rogers J.G. Comparing improvements in functional capacity in NYHA Class IV patients between a continuous flow left ventricular device and cardiac resynchronisation therapy. J Am Coll Cardiol 51 Suppl. A (2008) A69(Abstr)
18. Moore S.A., Clark N., Madsen C.N., Bishop C.J., Nelson K., and Long J.W. Destination left ventricular assist device therapy for advanced age patients with heart failure: is there an age limit. J Am Coll Cardiol 51 Suppl. A (2008) A68(Abstr)
19. Westaby S. Advanced heart failure-an "off the shelf" solution?. Lancet 371 9628 (2008) 1898-1900
20. Thekkudan J., Rogers C., Thomas H.L., Bonser R.S., Banner N.R., and Steering Group. Trends in adult heart transplantation: a UK survey. J Heart-Lung Transplant 27 Suppl. 2 (2008) S.122(Abstr)
21. Hetzer R., Muller J., Weng Y., Wallukat G., Spiegelsberger S., and Loebe M. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg 68 (1999) 742-749
22. Lee D.S., Austin P.C., Rouleau J.L., Liu P.P., Naimark D., and Tu J.V. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290 (2003) 2581-2587
23. Leitz K., and Miller L.W. Improved survival of patents with end-stage heart failure listed for heart transplantation. J Am Coll Cardiol 50 (2007) 1282-1290
24. Westaby S. Lifetime circulatory support must not be restricted to transplant centres. Heart Failure Clin 3 (2007) 369-376